Balyasny Asset Management Portfolio holdings
AUM
$44B
1-Year Return
17.37%
This Quarter Return
+7.86%
1 Year Return
+17.37%
3 Year Return
+72.12%
5 Year Return
+152.69%
10 Year Return
+378.29%
AUM
$39B
AUM Growth
+$2.9B
(+8%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-3.02%
Top 10 Holdings %
Top 10 Hldgs %
10.59%
Holding
2,569
New
653
Increased
619
Reduced
612
Closed
586
Top Buys
| 1 |
Broadcom
AVGO
|
+$366M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$309M |
| 4 |
Baker Hughes
BKR
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$239M |
Top Sells
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$686M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$447M |
| 3 |
Union Pacific
UNP
|
+$350M |
| 4 |
HES
Hess
HES
|
+$330M |
| 5 |
Deere & Co
DE
|
+$313M |
Sector Composition
| 1 | Technology | 14.13% |
| 2 | Consumer Discretionary | 13.02% |
| 3 | Industrials | 11.91% |
| 4 | Financials | 11.63% |
| 5 | Healthcare | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Medallion Financial
MFIN
$248M
| $251K | ﹤0.01% |
31,768
-21,677
| -41% | -$171K |
|
1677
Western New England Bancorp
WNEB
$251M
| $251K | ﹤0.01% |
32,698
-18,350
| -36% | -$141K |
|
1678
CRA International
CRAI
$1.31B
| $249K | ﹤0.01% |
+1,664
| New | +$249K |
|
1679
Jasper Therapeutics
JSPR
$41.6M
| $247K | ﹤0.01% |
+8,417
| New | +$247K |
|
1680
OceanFirst Financial
OCFC
$1.05B
| $247K | ﹤0.01% |
+15,027
| New | +$247K |
|
|
SWN
1681
DELISTED
Southwestern Energy Company
SWN
| $246K | ﹤0.01% |
32,519
-3,965
| -11% | -$30.1K |
|
1682
Metallus
MTUS
$710M
| $245K | ﹤0.01% |
+11,023
| New | +$245K |
|
1683
Rush Street Interactive
RSI
$2.05B
| $245K | ﹤0.01% |
37,669
-263,567
| -87% | -$1.72M |
|
1684
CorVel
CRVL
$4.53B
| $245K | ﹤0.01% |
2,793
-10,038
| -78% | -$880K |
|
1685
Gyre Therapeutics
GYRE
$738M
| $244K | ﹤0.01% |
+13,979
| New | +$244K |
|
1686
HSBC
HSBC
$239B
| $244K | ﹤0.01% |
6,206
-59,019
| -90% | -$2.32M |
|
1687
Blue Bird Corp
BLBD
$1.85B
| $242K | ﹤0.01% |
+6,311
| New | +$242K |
|
1688
Everspin Technologies
MRAM
$155M
| $242K | ﹤0.01% |
30,524
-17,777
| -37% | -$141K |
|
1689
Johnson Outdoors
JOUT
$420M
| $241K | ﹤0.01% |
+5,236
| New | +$241K |
|
1690
Wheels Up
UP
$1.51B
| $240K | ﹤0.01% |
+83,760
| New | +$240K |
|
|
INZY
1691
DELISTED
Inozyme Pharma
INZY
| $240K | ﹤0.01% |
+31,380
| New | +$240K |
|
1692
Royal Bank of Canada
RY
$205B
| $239K | ﹤0.01% |
2,370
-42,088
| -95% | -$4.25M |
|
1693
ESCO Technologies
ESE
$5.43B
| $239K | ﹤0.01% |
2,233
-4,415
| -66% | -$473K |
|
1694
Fulgent Genetics
FLGT
$681M
| $239K | ﹤0.01% |
+10,994
| New | +$239K |
|
1695
WNS Holdings
WNS
$3.25B
| $237K | ﹤0.01% |
4,700
-1,554
| -25% | -$78.5K |
|
1696
Unifirst Corp
UNF
$3.27B
| $237K | ﹤0.01% |
1,368
-1,613
| -54% | -$280K |
|
1697
Apogee Therapeutics
APGE
$2.22B
| $237K | ﹤0.01% |
+3,561
| New | +$237K |
|
1698
INmune Bio
INMB
$52.4M
| $236K | ﹤0.01% |
20,047
-3,211
| -14% | -$37.7K |
|
1699
Brown-Forman Class B
BF.B
$13B
| $234K | ﹤0.01% |
4,541
-3,842
| -46% | -$198K |
|
|
CRGX
1700
DELISTED
CARGO Therapeutics
CRGX
| $234K | ﹤0.01% |
+10,464
| New | +$234K |
|